In this episode, host Jordan Burgin sits down with Carine Schorochoff, CEO of Cardiawave, to explore Valvosoft the world’s first CE-marked non-invasive ultrasound therapy for severe symptomatic aortic stenosis.

With 30-plus years in structural heart across J&J, Medtronic, Edwards Lifesciences, and two startup CEO roles, Carine breaks down why the technology has delivered 0% stroke rates across 125 procedures, what it actually means to treat a calcified aortic valve without entering the body, and how Cardiawave is now navigating the FDA pathway with a €55M raise on the horizon.